Platelet-erythrocyte interactions enhance αIIbβ3 integrin receptor activation and P-selectin expression during platelet recruitment: Down-regulation by aspirin ex vivo

Blood

Volumn 99, Issue 11, 2002, Pages 3978-3984

  Vallés, Juana ^a,b,c   Teresa Santos, M ^a,b,c   Aznar, Justo ^a,b,c   Martínez, Marcial ^a,b,c   Moscardó, Antonio ^a,b,c   Piñón, Marta ^a,b,c   Johan Broekman, M ^a,b,c   Marcus, Aaron J ^a,b,c  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLSALICYLIC ACID; ARACHIDONIC ACID; BETA3 INTEGRIN; CALCIUM ION; FLUORESCEIN ISOTHIOCYANATE; GLYCOPROTEIN IIB; PADGEM PROTEIN; PHOSPHATIDYLSERINE; PROSTACYCLIN; THROMBOXANE A2;

ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOGENESIS;

EID: 0036624890     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.11.3978     Document Type: Article

References (47)

1. Marcus AJ. Platelets: Their role in hemostasis, thrombosis and inflammation. In: Gallin JI, Snyderman R, eds. Inflammation: Basic Principles and Clinical Correlates. Philadelphia, PA: Lippincott Williams & Wilkins; 1999:77-95.
2. Santos MT, Valles J, Aznar J, Pérez-Requejo JL. Role of red blood cells in the early stage of platelet activation by collagen. Thromb Haemostas. 1986;56:376-381.
3. Santos MT, Valles J, Marcus AJ, et al. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. J Clin Invest. 1991;87:571-580.
4. Valles J, Santos MT, Aznar J, et al. Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, ADP release, and recruitment. Blood. 1991;78:154-162.
5. Valles J, Santos MT, Marcus AJ, et al. Downregulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesive proteins. J Clin Invest. 1993;92:1357-1365.
6. Shattil SJ, Kashiwagi H, Pampori N. Integrin signaling: The platelet paradigm. Blood. 1998;91:2645-2657.
7. Diacovo TG, Roth SJ, Buccola JM, Bainton DF, Springer TA. Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta(2)-integrin CD11b/CD18. Blood. 1996;88:146-157.
8. IIb3 and stimulated by platelet-activating factor. J Clin Invest. 1997;100:2085-2093.
9. Berman CL, Yeo EL, Wencel-Drake JD, Furie BC, Ginsberg MH, Furie B. A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. Characterization and subcellular localization of platelet activation-dependent granule-external membrane protein. J Clin Invest. 1986;78:130-137.
10. Merten M, Thiagarajan P. P-selectin expression on platelets determines size and stability of platelet aggregates. Circulation. 2000;102:1931-1936.
11. Schmidtke DW, Diamond SL. Direct observation of membrane tethers formed during neutrophil attachment to platelets or P-selectin under physiological flow. J Cell Biol, 2000;149:719-730.
12. McEver RP, Cummings RD. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest. 1997;100:485-492.
13. Yang J, Furie BC, Furie B. The biology of P-selectin glycoprotein ligand-1: Its role as a selectin counterreceptor in leukocyte-endothelial and leukocyte-platelet interaction. Thromb Haemost. 1999;81:1-7.
14. Kogaki S, Sawa Y, Sano T, et al. Selectin on activated platelets enhances neutrophil endothelial adherence in myocardial reperfusion injury. Cardiovasc Res. 1999;43:968-973.
15. Palabrica T, Lobb R, Furie BC, et al. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature. 1992;359:848-851.
16. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: Structures, properties, and functions. Physiol Rev. 1999;79:1193-1226.
17. Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood. 1997;89:1121-1132.
18. Kuypers FA. Phospholipid asymmetry in health and disease. Curr Opin Hematol. 1998;5:122-131.
19. Martin DW, Jesty J. Calcium stimulation of procoagulant activity in human erythrocytes - ATP dependence and the effects of modifiers of stimulation and recovery. J Biol Chem. 1995;270:10468-10474.
20. Manodori AB, Barabino GA, Lubin BH, Kuypers FA. Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin. Blood. 2000;95:1293-1300.
21. Closse C, Dacharyprigent J, Boisseau MR. Phosphatidylserine-related adhesion of human erythrocytes vascular endothelium. Br J Haematol. 1999;107:300-302.
22. Antonucci R, Walker R, Herion J, Orringer E. Enhancement of sickle erythrocyte adherence to endothelium by autologous platelets. Am J Hematol. 1990;34:44-48.
23. Brittain HA, Eckman JR, Swerlick RA, Howard RJ, Wick TM. Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: A potential role for platelet activation in sickle cell vaso-occlusion. Blood. 1993;81:2137-2143.
24. Brittain JE, Mlinar KJ, Anderson CS, Orringer EP, Parise LV. Activation of sickle red blood cell adhesion via integrin-associated protein/CD47-induced signal transduction. J Clin Invest. 2001;107:1555-1562.
25. 2+ influx and cAMP-mediated signaling pathways. Am J Physiol Cell Physiol. 1997;42;C1828-C1834.
26. Andrews DA, Low PS. Role of red blood cells in thrombosis. Curr Opin Hematol. 1999;6:76-82.
27. Soldati L, Spaventa R, Vezzoli G, et al. Characterization of voltage-dependent calcium influx in human erythrocytes by Fura-2. Biochem Biophys Res Comm. 1997;236:549-554.
28. 2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440-3450.
29. Poenie M, Alderton J, Tsien RY, Stinhardt RA. Changes of free calcium levels with the stages of the cell division cycle. Nature. 1985;315:147-149.
30. 2+-indicator Fura-2. Cell Calcium. 1988;9:167-179.
31. Shattil SJ, Cunningham M, Hoxie J. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood. 1987;70:307-315.
32. Kuypers FA, Lewis RA, Hua M, et al. Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. Blood. 1996;87:1179-1187.
33. Santos MT, Valles J, Aznar J, Marcus AJ, Broekman MJ, Safier LB. Prothrombotic effects of erythrocytes on platelet reactivity: Reduction by aspirin. Circulation. 1997;95:63-68.
34. Celi A, Pellegrini G, Lorenzet R, et al. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci U S A. 1994;91:8767-8771.
35. Evangelista V, Manarini S, Sideri R, et al. Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: Role of PSGL-1 as a signaling molecule. Blood. 1999;93:876-885.
36. Furman MI, Grigoryev D, Bray PF, Dise KR, Goldschmidt-Clermont PJ. Platelet tyrosine kinases and fibrinogen receptor activation. Circ Res. 1994;75:172-180.
37. 3 integrin receptor activation and aspirin-insensitive mechanisms of thrombin-stimulated human platelets. Circulation. 2000;102:1924-1930.
38. Rinder CS, Student LA, Bonan JL, Rinder HM, Smith BR. Aspirin does not inhibit adenosine diphosphate-induced platelet alpha-granule release. Blood. 1993;82:505-512.
39. Brash AR. Arachidonic acid as a bioactive molecule. J Clin Invest. 2001;107:1339-1345.
40. 2+ channel in human erythrocytes. Blood. 2000;95:2420-2425.
41. +-channel in human erythrocytes and alters cell volume and filterability. J Biol Chem. 1996;271:18651-18656.
42. Minetti G, Low PS. Erythrocyte signal transduction pathways and their possible functions. Curr Opin Hematol. 1997;4:116-121.
43. Wood BL, Gibson DF, Tait JF. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: Flow-cytometric measurement and clinical associations. Blood. 1996;88:1873-1880.
44. Kuypers FA, Yuan J, Lewis RA, et al. Membrane phospholipid asymmetry in human thalassemia. Blood. 1998;91:3044-3051.
45. Ruf A, Pick M, Deutsch V, et al. In-vivo platelet activation correlates with red cell arionic phospholipid exposure in patients with beta-thalassaemia major. Br J Haematol. 1997;98:51-56.
46. Key NS, SlungaardA, Dandelet L, et al. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood. 1998;91:4216-4223.
47. Helley D, Eldor A, Girot R, Ducrocq R, GuiIlin MC, Bezeaud A. Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and beta-thalassemia. Thromb Haemost, 1996;76:322-327.